Skip to main content
. 2001 Nov 5;194(9):1195–1206. doi: 10.1084/jem.194.9.1195

Figure 3.

Figure 3.

Inhibition of mammary carcinogenesis in Balb-neuT mice with MitC-treated allogeneic Neu/H-2q cells plus IL-12. Groups of eight mice received the indicated treatments. Tumor-free survival curves are significantly different (P < 0.0005 by the Mantel-Haenszel test). Tumor multiplicity is calculated as the cumulative number of incident tumors/total number of mice and is shown as mean ± SEM.